Attached files
| file | filename |
|---|---|
| 10-K - FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 - HUMANIGEN, INC | s82516010k.htm |
| EX-32.2 - EXHIBIT 32.2 - HUMANIGEN, INC | ex32_2.htm |
| EX-31.2 - EXHIBIT 31.2 - HUMANIGEN, INC | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - HUMANIGEN, INC | ex31_1.htm |
| EX-23.2 - EXHIBIT 23.2 - HUMANIGEN, INC | ex23_2.htm |
| EX-23.1 - EXHIBIT 23.1 - HUMANIGEN, INC | ex23_1.htm |
EXHIBIT 32.1
CERTIFICATION OF
CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Cameron Durrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of KaloBios Pharmaceuticals, Inc. on Form 10-K for the year ended December 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that information contained in such Annual Report of KaloBios Pharmaceuticals, Inc. on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of KaloBios Pharmaceuticals, Inc..
|
By:
|
/s/ Cameron Durrant
|
||
|
Name:
|
Cameron Durrant
|
||
|
Title:
|
Chief Executive Officer (Principal Executive Officer)
|
||
|
Date:
|
September 1, 2016
|
||